Terence Rooney
Fortune : 4 M $ au 31/07/2026
Fortune : 4 M $ au 31/07/2026
Terence Rooney is currently Chief Medical Officer at Kymera Therapeutics, Inc. starting in 2026.
Formerly, Dr. Rooney was Medical Director-Rheumatoid Arthritis at Eli Lilly & Co. Education includes a doctorate from the Royal College of Surgeons.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/07/2026 | 38 000 ( 0,05 % ) | 4 M $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 27/07/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/02/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Royal College of Surgeons
Royal College of Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national